Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$469000.0.

  • NeuroPace's Other Working Capital Changes fell 1411.19% to -$469000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year decrease of 6483.52%. This contributed to the annual value of -$1.6 million for FY2024, which is 1498.23% down from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Other Working Capital Changes is -$469000.0, which was down 1411.19% from -$461000.0 recorded in Q2 2025.
  • NeuroPace's Other Working Capital Changes' 5-year high stood at $2.8 million during Q2 2021, with a 5-year trough of -$1.1 million in Q4 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$465000.0 (2023), whereas its average is -$297888.9.
  • Over the last 5 years, NeuroPace's Other Working Capital Changes had its largest YoY gain of 440000.0% in 2021, and its largest YoY loss of 323076.92% in 2021.
  • Quarter analysis of 5 years shows NeuroPace's Other Working Capital Changes stood at -$1.1 million in 2021, then skyrocketed by 49.76% to -$534000.0 in 2022, then skyrocketed by 121.54% to $115000.0 in 2023, then tumbled by 465.22% to -$420000.0 in 2024, then fell by 11.67% to -$469000.0 in 2025.
  • Its Other Working Capital Changes was -$469000.0 in Q3 2025, compared to -$461000.0 in Q2 2025 and -$450000.0 in Q1 2025.